Prognostic factors in anal carcinoma- Role of p16 and tumour infiltrating lymphocytes (TIL)

This stimulating paper came from this tweet:

#ClinicalOncology Editor's choice 👇🏾🥳🎉 https://t.co/YJ6b7lnfl9

— Prof Ananya💙 (@achoud72) September 22, 2021

The PDF appears here:

Wakeham, K., L. Murray, R. Muirhead, M. A. Hawkins, D. Sebag-Montefiore, S. Brown, L. Murphy, et al. 2021. “Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy.” Clinical Oncology 33 (10): 638–49. https://doi.org/10.1016/j.clon.2021.04.015.

My summary of the key points appears below:

[embeddoc url=”https://radoncnotescom.files.wordpress.com/2022/01/3af88-wakeham_etal_multicentreinvestigationprognosticfactorsincorporating_2021.docx”%5D

Please share!